
Aviwell is a deep tech startup leveraging a revolutionary AI/ML Discovery Platform to develop natural, sustainable feed solutions that improve animal growth and health for livestock producers worldwide. Their proprietary in-silico and in-vivo approach, based on 30 years of pioneering research into the microbiota gut-brain axis and AI techniques, enables them to create microbiota-based nutritional products that foster healthy animal growth at a fraction of the cost. Aviwell aims to address global food security by providing healthier, sustainable alternatives to traditional animal feed, targeting the $6.6 trillion agri-food industry and 139 billion livestock and fish worldwide. Their key products include the AI-driven Discovery Platform Aneto™ and a range of natural direct-fed microbials called Nectar™. Aviwell has attracted significant seed funding and international attention as a pioneer in sustainable agri-food innovation.

Aviwell is a deep tech startup leveraging a revolutionary AI/ML Discovery Platform to develop natural, sustainable feed solutions that improve animal growth and health for livestock producers worldwide. Their proprietary in-silico and in-vivo approach, based on 30 years of pioneering research into the microbiota gut-brain axis and AI techniques, enables them to create microbiota-based nutritional products that foster healthy animal growth at a fraction of the cost. Aviwell aims to address global food security by providing healthier, sustainable alternatives to traditional animal feed, targeting the $6.6 trillion agri-food industry and 139 billion livestock and fish worldwide. Their key products include the AI-driven Discovery Platform Aneto™ and a range of natural direct-fed microbials called Nectar™. Aviwell has attracted significant seed funding and international attention as a pioneer in sustainable agri-food innovation.
Headquarters: Toulouse, France (office in Lowell, MA, USA)
Business: Deep-tech AI/ML platform for microbiota-based animal nutrition (Aneto™) and direct-fed microbials (Nectar™)
Founded: 2016
Employees: 23
Recent funding: €11M Series A (announced Jan 23, 2026)
Sustainable animal nutrition and health via microbiota-informed feed products.
2016
Biotechnology
€9,000,000
Seed round announced July 18, 2023
€11,000,000
Series A announced January 23, 2026
“3CC | Third Culture Capital, Blast. Club, Bpifrance, Elaia, European Innovation Council, Hatch Blue Ltd, MFS Investment Management, Swen Capital Partners”
| Company |
|---|
Microbiology Laboratory Technician /Technicien(ne) de laboratoire
Toulouse, Occitanie, France
About the job
Aviwell operates at the convergence of DIGITAL & LIFE SCIENCES. Our mission is to develop natural and sustainable solutions to improve animal health to better nourish and provide FOOD SECURITY to the 8 billion people on our planet... and to do so at a fraction of the cost. We are a deep-tech startup with our HQ in Toulouse, France and with sales offices in Boston, USA.
The company is based on three disruptive assets:
When combined, we have the ability to develop revolutionary feed solutions for farmers that significantly improve animal growth and health. Aviwell aims to market these unique products on a global market.
In order to support its research and innovation department, Aviwell is recruiting a highly talented Microbiology Laboratory Technician for a full-time position. The candidate will be responsible for supporting the platform for isolating and characterizing anaerobic bacteria, including upscaling production for animal studies and genomic sequencing. The candidate will be experienced in microbial isolation, cultivation, and characterization. The candidate will be experienced in preparation of general laboratory media and reagents, and general molecular biology procedures.
Summary of Job Responsibilities
Location:
Minimum Education:
Minimum Work Requirements:
Skills:
Contract & Start Date:
The position will begin as a CDD (1 year) with the potential to transition to a CDI.
Salary will be competitive and commensurate with experience.
Expected start date: January 2026, with the possibility to start in February.